A59-12400-20208
3 vaccinations
9 coded responses
19 check-ins
9 free-text entries
2 call cases
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 951 / CA
- Registered
- 2021-02-15
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-10
Dose 1 — Pfizer-BioNTech
-
2021-02-15
Registered in v-safe
-
2021-02-17
Survey response — day 7, dose 1MedDRA: Insomnia — Feeling: Poor · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Sleepless nightv, no sleep pill.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-25
-
2021-03-03
Dose 2 — Pfizer-BioNTech
-
2021-03-03
Survey response — day 0, dose 2MedDRA: No adverse event — Feeling: Fair · Fatigue or tirednessFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-06
Survey response — days 1–6 daily, dose 2MedDRA: No adverse event — Feeling: GoodFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-07
Survey response — days 1–6 daily, dose 2MedDRA: No adverse event — Feeling: GoodFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-12
Health check-in — day 7, dose 2Feeling: Fair · Chills, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-03-17
Survey response — day 14, dose 2MedDRA: Cyst removal, Pre-existing disease, Sensory loss — Feeling: Good · Be unable to do your normal daily activitiesFree text: Had minor operation to remove Cyst.Have begun to lose sensation in legs - spinal osteophytes. I believe it has no relation to C-19.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-24
-
2021-03-31
Survey response — day 28, dose 2MedDRA: Unevaluable event — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Ageing!MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-07
- 2021-04-15
- 2021-06-02
- 2021-09-03
-
2022-02-18
Dose 3 — Pfizer-BioNTech
-
2022-03-03
Survey response — 12 months, dose 2MedDRA: Balance disorder, Discomfort, Fatigue, Malignant melanoma, Myalgia, Pre-existing disease, Surgery — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Symptoms: Muscle pain, off balance, off track,, increasing arthritic discomfort. New Melanoma, fatigue. · Healthcare visit (other): SurgeryMedDRA releases: 2024-11 · check-in free text available
-
2022-03-03
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-03-04
- 2022-03-06
- 2022-03-21
-
2022-03-28
Survey response — day 35, dose 3MedDRA: Fatigue — Feeling: Fair · Be unable to do your normal daily activitiesFree text: ExhaustedppMedDRA releases: 2024-11 · check-in free text available
- 2022-04-01
-
2022-05-20
Survey response — 3 months, dose 3MedDRA: Balance disorder, Gait disturbance, Quarantine — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: What may be neuropathy in my legs and much Imnbalance when walking This. Has been with me since our quarantine, whenever that wasMedDRA releases: 2024-11 · check-in free text available
-
2022-05-20
Report sent to call center — 3 months, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-05-23
- 2022-05-23
-
2022-05-23
Call successfulNot applicable - Accidental Reporting
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-10 | Pfizer-BioNTech | |
| 2 | 2021-03-03 | Pfizer-BioNTech | |
| 3 | 2022-02-18 | Pfizer-BioNTech | No |
Call center
2 call center cases
1 successful · 1 unsuccessful
Free text
Release 4 — day 7, dose 1
Systemic reaction (other): Sleepless nightv, no sleep pill.
Release 5 — day 0, dose 2
Systemic reaction (other): No
Release 5 — days 1–6 daily, dose 2
Systemic reaction (other): No
Systemic reaction (other): No
Release 5 — day 14, dose 2
Symptoms: Had minor operation to remove Cyst.Have begun to lose sensation in legs - spinal osteophytes. I believe it has no relation to C-19.
Release 6 — day 28, dose 2
Symptoms: Ageing!
Release 11 — 12 months, dose 2
Symptoms: Muscle pain, off balance, off track,, increasing arthritic discomfort. New Melanoma, fatigue.
Healthcare visit (other): Surgery
Release 11 — day 35, dose 3
Symptoms: Exhaustedpp
Release 11 — 3 months, dose 3
Symptoms: What may be neuropathy in my legs and much Imnbalance when walking This. Has been with me since our quarantine, whenever that was
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Surgery | · | · | ✓ |
| SD | Balance disorder | · | · | ✓ |
| SD | Cyst removal | ✓ | ✓ | ✓ |
| SD | Discomfort | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Gait disturbance | · | · | ✓ |
| SD | Malignant melanoma | · | · | ✓ |
| SD | Myalgia | · | · | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Quarantine | · | · | ✓ |
| SD | Sensory loss | ✓ | ✓ | ✓ |
| SD | Unevaluable event | ✓ | ✓ | ✓ |
| SRO | Insomnia | ✓ | ✓ | ✓ |
| SRO | No adverse event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release